Home
TPST

TPST

Tempest Therapeutics Inc.

as of 12-10-2025 3:18pm EST

$3.19

$0.01

-0.31%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Chart Type:

Time Range:

Founded:	2011	Country:	United States
Employees:	N/A	City:	BRISBANE
Market Cap:	14.9M	IPO Year:	N/A
Target Price:	$12.50	AVG Volume (30 days):	243.0K
Analyst Decision:	Hold	Number of Analysts:	2
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-9.71	EPS Growth:	N/A
52 Week Low/High:	$3.00 - $13.65	Next Earning Date:	11-05-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered TPST Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 69.74%

69.74%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full TPST Forecast & Prediction with Hourly Data

Compare TPST vs Leading Stocks

See how TPST stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free TPST Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "TPST Tempest Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.